Stifel Reiterates Hold Rating on Medtronic, Inc. (MDT)

Stifel analyst Rick Wise reiterated a Hold rating and $87.00 price target on Medtronic, Inc. (NYSE: MDT).

The analyst commented, “the company's F3Q25 revenues at $8.292B, versus Stifel/Consensus $8.313B/$8.331B, and 4.1% organic revenue, versus Stifel/ Consensus ~4.8%, both fell modestly below Stifel/Consensus projections. Surgical Innovations division (~25% of sales, down -0.4% y/y) distributor de-stocking was a key underperformance driver."

Also, "The company believes the de-stocking is a one-time event, and does not suggest softening underlying physician laparoscopic demand.”

For an analyst ratings summary and ratings history on Medtronic, Inc. click here. For more ratings news on Medtronic, Inc. click here.

Shares of Medtronic, Inc. closed at $86.07 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)